Oncoinvent Competitors and Similar CompaniesClear all
Oncoinvent's competitors and similar companies include enVVeno and Kymab.
 enVVeno Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). |  Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | ||
Founding Date | Founding Date 2010 | Founding Date 1987 | Founding Date 2009 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Oslo, NO HQ | Locations Irvine, US HQ | Locations Cambridge, GB HQ |
Employees | Employees 442% decrease | Employees 1525% increase | Employees 407% decrease |
Funding | |||
Latest funding round | Latest funding round $ 4m (about 6 years ago) | Latest funding round N/A | Latest funding round $ 100m (over 9 years ago) |
Total funding raised | Total funding raised $ 29m | Total funding raised N/A | Total funding raised $ 220.4m |
For sources of this data, please see the company profile
View Company Profiles
enVVeno
HQ
Irvine, US
Employees
15↑ 25% increase
Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).
View companyKymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View company